Marketing-authorisation holder
Merial
11 medicines in 1 country, as authorisation holder.
Group structure
Part of
MerialPharmaceutical groupOther companies in the group
Canada1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
11 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Bovalto Ibraxion | Infectious bovine rhinotracheitis vaccine | EU (EMA) | Withdrawn | 2000 |
| BTVPUR AlSap 1 | Bluetongue-virus serotype-1 antigen | EU (EMA) | Withdrawn | 2010 |
| BTVPUR AlSap 2-4 | Inactivated adjuvanted vaccine against bluetongue virus serotype and infections | EU (EMA) | Withdrawn | 2010 |
| BTVPUR Alsap 8 | Adjuvanted bluetongue virus vaccine | EU (EMA) | Withdrawn | 2009 |
| Certifect | Fipronil amitraz -methoprene | EU (EMA) | Withdrawn | 2011 |
| Eurifel RCP FeLV | Vaccine against feline viral rhinotracheitis, calicivirosis, panleucopenia and leukaemia in cats | EU (EMA) | Withdrawn | 2002 |
| Gripovac 3 | Inactivated influenza-a virus | EU (EMA) | Withdrawn | 2010 |
| Longrange | Eprinomectin | EU (EMA) | Refused | |
| Oncept Melanoma | EU (EMA) | Refused | ||
| Parvoduk | Live attenuated muscovy duck parvovirus | EU (EMA) | Cancelled | 2014 |
| Purevax RCCh | Vaccine against feline viral rhinotracheitis, feline calicivirosis and feline chlamydophila infections | EU (EMA) | Cancelled | 2005 |